October 07, 2022
A special master in Delaware has recommended clearing DLA Piper to represent a Dutch developer of biomedical mice in the company's patent lawsuit against a rival recently purchased by Amgen, despite the BigLaw firm's ongoing work handling "environmental, social, and governance initiatives" for Amgen.